Exelixis Inc (NAS:EXEL)
$ 36.115 0.265 (0.74%) Market Cap: 10.31 Bil Enterprise Value: 9.21 Bil PE Ratio: 23.15 PB Ratio: 4.54 GF Score: 91/100

Q4 2023 Exelixis Inc Earnings Call Transcript

Feb 06, 2024 / 10:00PM GMT
Release Date Price: $21.83 (+2.01%)
Operator

Good day, ladies and gentlemen, and welcome to the Exelixis Fourth Quarter and Fiscal Year 2023 Financial Results Conference Call. My name is Towanda, and I'll be your operator for today. As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to your host today, Ms. Susan Hubbard, Executive Vice President of Public Affairs and Investor Relations.

Susan T. Hubbard
Exelixis, Inc. - EVP of Public Affairs & IR

Thank you, Towanda, and thank you all for joining us for the Exelixis Fourth Quarter and Fiscal Year 2023 Financial Results Conference Call. Joining me on today's call are Mike Morrissey, our President and CEO; and Chris Senner, our Chief Financial Officer, who will review our progress for the fourth quarter and full year 2023 ended December 29, 2023. P.J. Haley, our Executive Vice President of Commercial; Amy Peterson, our Chief Medical Officer; and Dana Aftab, our Chief Scientific Officer, are also on the call today and will participate in the question-and-answer portion of the call.

During the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot